Baird Medical Investment Holdings Limited (BDMD)
| Market Cap | 109.44M |
| Revenue (ttm) | 31.86M |
| Net Income (ttm) | -3.17M |
| Shares Out | 36.73M |
| EPS (ttm) | -0.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,394,066 |
| Open | 2.280 |
| Previous Close | 2.280 |
| Day's Range | 2.101 - 3.140 |
| 52-Week Range | 0.757 - 7.262 |
| Beta | -1.08 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 15, 2026 |
About BDMD
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as soft tissue ablation. It sells its products through third-party distri... [Read more]
Financial Performance
In 2024, BDMD's revenue was $37.04 million, an increase of 17.74% compared to the previous year's $31.46 million. Earnings were $12.45 million, an increase of 18.09%.
Financial StatementsNews
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology
NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences
NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial Hospital
NEW YORK, Feb. 11, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and Japan
NEW YORK, Feb. 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technolo...
Baird Medical Successfully Concludes Gynecology Microwave Ablation Masterclass
NEW YORK, Jan. 28, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) techno...
Baird Medical Accelerates Global Commercial Roadmap through Strategic Partnership with Stonewood Key Capital
NEW YORK, Jan. 26, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Highlights Strategic Engagement at 2026 J.P. Morgan Healthcare Conference
NEW YORK, Jan. 20, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam
NEW YORK, Jan. 7, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, today announced...
Baird Medical Establishes U.S. Manufacturing Base to Accelerate Global Expansion and Future R&D
NEW YORK , Dec. 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, today announc...
Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion
NEW YORK , Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation
NEW YORK , Nov. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its official l...
Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York Practice
NEW YORK , Oct. 27, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the clinical ...
Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh
NEW YORK , Oct. 23, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successfu...
Baird Medical Fosters Advanced Physician Training at International Thyroid Microwave Ablation Workshop in Malaysia
NEW YORK , Oct. 21, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successfu...
Baird Medical Champions Global Collaboration in Microwave Ablation at International Thyroid Workshop
NEW YORK , Oct. 20, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participa...
Baird Medical's MWA Technology Successfully Treats Large Thyroid Nodules at UCSF Health
NEW YORK , Oct. 16, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) techno...
Baird Medical Highlights Johns Hopkins University Research Demonstrating Clinical and Economic Benefits of Thyroid Nodule Ablation
NEW YORK , Oct. 14, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("BAIRD MEDICAL" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) techno...
Baird Medical Concludes Successful Participation at ACS Clinical Congress 2025 with Strong Interest in MWA Technology
NEW YORK , Oct. 9, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Showcases Advanced Microwave Ablation Technology at the 2025 ACS Clinical Congress
NEW YORK , Oct. 6, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Advances Microwave Ablation Training at Leading U.S. Thyroid Centers
NEW YORK , Oct. 1, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Showcases Advanced Ablation Technology at 2025 American Thyroid Association Annual Meeting
NEW YORK , Sept. 29, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd.
Baird Medical Engages Global Clinical Leaders at AAES 2025
NEW YORK , May 19, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Advances Thyroid MWA Training and Academic Exchange with Leading Harvard Professor
NEW YORK , May 12, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in Microwave Ablation (MWA) technology, recently hosted an ad...
Baird Medical to Participate in the AAES 2025 Annual Meeting
NEW YORK , May 6, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technolo...
Baird Medical to Participate in COSM 2025 Conference
NEW YORK , May 5, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technolo...